These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35714942)

  • 21. Integrin α
    Fu S; Zhao Y; Sun J; Yang T; Zhi D; Zhang E; Zhong F; Zhen Y; Zhang S; Zhang S
    Colloids Surf B Biointerfaces; 2021 May; 201():111623. PubMed ID: 33636597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
    Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
    Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY
    Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
    Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
    J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic RGD-Functionalized
    Kawai K; Nishimura K; Okada S; Sato S; Suzuki M; Takata T; Nakamura H
    Mol Pharm; 2020 Oct; 17(10):3740-3747. PubMed ID: 32845640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Nanotargeted
    Liu SY; Lo SN; Lee WC; Hsu WC; Lee TW; Chang CH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of linear and cyclic peptide-PEG-lipids for stabilization and targeting of cationic liposome-DNA complexes.
    Ewert KK; Kotamraju VR; Majzoub RN; Steffes VM; Wonder EA; Teesalu T; Ruoslahti E; Safinya CR
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1618-1623. PubMed ID: 26874401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling the role of β1 integrin isoforms in cRGD-mediated uptake of nanoparticles bearing hydrophilized alkyne moieties in epithelial and endothelial cells.
    Zhang W; Teske N; Samadi M; Sarem M; Shastri VP
    Acta Biomater; 2020 Oct; 116():344-355. PubMed ID: 32871280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
    Bianchi A; Arosio D; Perego P; De Cesare M; Carenini N; Zaffaroni N; De Matteo M; Manzoni L
    Org Biomol Chem; 2015 Jul; 13(27):7530-41. PubMed ID: 26074454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenic vessel-targeting DDS by liposomalized oligopeptides.
    Asai T; Oku N
    Methods Mol Biol; 2010; 605():335-47. PubMed ID: 20072892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimerization of cRGD peptides by click chemistry: synthetic strategies, chemical limitations, and influence on biological properties.
    Wängler C; Maschauer S; Prante O; Schäfer M; Schirrmacher R; Bartenstein P; Eisenhut M; Wängler B
    Chembiochem; 2010 Oct; 11(15):2168-81. PubMed ID: 20827791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an apolipoprotein E mimetic peptide-lipid conjugate for efficient brain delivery of liposomes.
    Kato N; Yamada S; Suzuki R; Iida Y; Matsumoto M; Fumoto S; Arima H; Mukai H; Kawakami S
    Drug Deliv; 2023 Dec; 30(1):2173333. PubMed ID: 36718920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of a novel adapter lipid using Fc-region mediated antibody modification for post-insert preparation of transferrin receptor targeted messenger RNA-loaded lipid nanoparticles.
    Kato N; Moriya N; Matsumoto M; Matsuo A; Yoshida M; Hiu T; Matsuo T; Takashima Y; Kamiya M; Mukai H; Kawakami S
    Eur J Pharm Biopharm; 2024 Oct; 203():114468. PubMed ID: 39173936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect.
    Liu H; Zhang R; Zhang D; Zhang C; Zhang Z; Fu X; Luo Y; Chen S; Wu A; Zeng W; Qu K; Zhang H; Wang S; Shi H
    Int J Nanomedicine; 2022; 17():227-244. PubMed ID: 35068931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA.
    Alam MR; Ming X; Fisher M; Lackey JG; Rajeev KG; Manoharan M; Juliano RL
    Bioconjug Chem; 2011 Aug; 22(8):1673-81. PubMed ID: 21755983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells.
    Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
    Biomaterials; 2013 Jul; 34(22):5617-27. PubMed ID: 23623323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
    Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
    Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
    Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
    Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.